Name: Milestone Pharmaceuticals Inc. (MIST) Balance Sheet
Creator: FinSpry

Milestone Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Milestone Pharmaceuticals Inc. (MIST) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	25.31	13.76	64.54	114.14	72.31	119.82
Short-Term Investments	44.38	52.24	56.95	0.00	70.00	0.00
Cash & Short-Term Investments	69.70	66.00	64.54	114.14	142.31	119.82
Accounts Receivable	1.72	1.45	0.88	0.48	0.95	0.26
Inventory	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.84	3.18	0.33	0.36	5.43	0.00
Total Current Assets	73.93	73.03	71.80	118.92	148.69	121.92
Non-Current Assets
Property, Plant & Equipment (Net)	1.57	2.19	2.68	0.93	1.29	0.93
Other Non-Current Assets	0.00	0.00	0.33	0.36	0.73	0.00
Total Non-Current Assets	1.57	2.19	2.68	0.93	2.01	0.93
Total Assets	75.50	75.23	74.48	119.85	149.97	122.85
Current Liabilities
Accounts Payable	1.93	3.98	5.64	4.38	4.64	8.00
Short-Term Debt	0.57	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	5.62	2.70	0.81	0.71	1.27	0.00
Other Current Liabilities	5.62	0.71	2.57	1.46	0.96	0.00
Total Current Liabilities	8.13	7.23	6.14	6.78	6.16	8.33
Non-Current Liabilities
Long-Term Debt	53.35	49.77	2.00	0.47	0.70	0.18
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	54.23	51.23	2.00	0.47	0.70	0.18
Total Liabilities	62.35	58.46	8.14	7.25	6.86	8.51
Stockholders' Equity
Common Stock	288.05	260.50	273.90	251.90	251.68	0.00
Retained Earnings	-367.55	-326.03	-266.34	-207.95	-163.47	-113.50
Accumulated Other Comprehensive Income	53.08	48.46	34.35	-1.63	46.37	0.00
Additional Paid-in Capital	39.57	33.83	24.44	15.71	8.53	3.81
Shares Outstanding	53.35	33.48	34.29	29.90	0.00	0.00
Total Stockholders' Equity	13.15	16.77	66.35	112.60	143.12	114.92
Total Liabilities & Equity	75.50	75.23	74.48	119.85	149.97	122.85